Evidence map›Paper›PMID 36578344›Full record

ReviewFrontiers in plant science2022

The hidden power of secondary metabolites in plant-fungi interactions and sustainable phytoremediation.

Neveen Atta Elhamouly, Omar A Hewedy, Amr Zaitoon, Angelica Miraples, Omnia T Elshorbagy, Suzan Hussien, Amira El-Tahan, Deliang Peng

Abstract readReview
In one paragraph

Review in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Mapping Evolution of Molecules across Biochemistry with Assembly Theory.Journal of chemical information and modeling · 2026
    Article
  6. Article
  7. Advances in the Control of Plant Fungal Pathogens.Journal of fungi (Basel, Switzerland) · 2026
    Review
  8. Genetic Dereplication of MultipleJournal of natural products · 2026
    Article
  9. Article
  10. Article
  11. Journal of fungi (Basel, Switzerland) · 2026
    Review
  12. Article
  13. Mechanisms of action and biocontrol potential ofFrontiers in fungal biology · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Fungus-derived opine enhances plant photosynthesis.Journal of advanced research · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Neveen Atta ElhamoulyState Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.
Omar A HewedyDepartment of Plant Agriculture, University of Guelph, Guelph, ON, Canada.
Amr ZaitoonDepartment of Food Science, University of Guelph, Guelph, ON, Canada.
Angelica MiraplesDepartment of Plant Agriculture, University of Guelph, Guelph, ON, Canada.
Omnia T ElshorbagySchool of Natural and Environmental Sciences, Faculty of Science, Agriculture & Engineering, Newcastle University, Newcastle upon Tyne, United Kingdom.
Suzan HussienBotany Department Faculty of Science, Mansoura University, Mansoura, Egypt.
Amira El-TahanPlant Production Department, Arid Lands Cultivation Research Institute, the City of Scientific Research and Technological Applications, City of Scientific Research and Technological Applications (SRTA-City), Borg El Arab, Alexandria, Egypt.
Deliang PengState Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global environment is dominated by various small exotic substances, known as secondary metabolites, produced by plants and microorganisms. Plants and fungi are particularly plentiful sources of these molecules, whose physiological functions, in many cases, remain a mystery. Fungal secondary metabolites (SM) are a diverse group of substances that exhibit a wide range of chemical properties and generally fall into one of four main family groups: Terpenoids, polyketides, non-ribosomal peptides, or a combination of the latter two. They are incredibly varied in their functions and are often related to the increased fitness of the respective fungus in its environment, often competing with other microbes or interacting with plant species. Several of these metabolites have essential roles in the biological control of plant diseases by various beneficial microorganisms used for crop protection and biofertilization worldwide. Besides direct toxic effects against phytopathogens, natural metabolites can promote root and shoot development and/or disease resistance by activating host systemic defenses. The ability of these microorganisms to synthesize and store biologically active metabolites that are a potent source of novel natural compounds beneficial for agriculture is becoming a top priority for SM fungi research. In this review, we will discuss fungal-plant secondary metabolites with antifungal properties and the role of signaling molecules in induced and acquired systemic resistance activities. Additionally, fungal secondary metabolites mimic plant promotion molecules such as auxins, gibberellins, and abscisic acid, which modulate plant growth under biotic stress. Moreover, we will present a new trend regarding phytoremediation applications using fungal secondary metabolites to achieve sustainable food production and microbial diversity in an eco-friendly environment.

Indexed as

Arbuscular mycorrhizal fungi (AMF)biotrophic fungiphytopathogenic fungiphytoremediationplant metabolic responsesecondary metabolitessiderophoresoil mycobiota

Identifiers

PMID36578344
PMCPMC9790997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.